The molecular pharmacology of organic anion transporters: from DNA to FDA?

被引：59
作者：
Eraly, SA
Bush, KT
Sampogna, RV
Bhatnagar, V
Nigam, SK
机构：
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[5] Vet Affairs Hosp, La Jolla, CA USA
来源：
MOLECULAR PHARMACOLOGY | 2004年 / 65卷 / 03期
关键词：
D O I：
10.1124/mol.65.3.479
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Renal organic anion secretion has been implicated in numerous clinically significant drug interactions and adverse reactions, indicating the importance of a detailed understanding of this pathway for the development of optimum therapeutics. With the cloning of multiple genes encoding organic anion transporters (OATs), the study of organic anion secretion has entered the molecular age. In this review, we focus on various aspects of the molecular biology and pharmacology of the OATs, including discussion of their structural biology, genomic organization in pairs, developmental regulation, toxicology, and pharmacogenetics. We propose functional, pathophysiological, and evolutionary hypotheses to help explain recent experimental and genomic data.
引用
收藏
页码：479 / 487
页数：9
相关论文
共 105 条
  • [1] Structure and mechanism of the lactose permease of Escherichia coli
    Abramson, J
    Smirnova, I
    Kasho, V
    Verner, G
    Kaback, HR
    Iwata, S
    [J]. SCIENCE, 2003, 301 (5633) : 610 - 615
  • [2] Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells
    Aslamkhan, AG
    Han, YH
    Yang, XP
    Zalups, RK
    Pritchard, JB
    [J]. MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 590 - 596
  • [3] Human organic anion transporters mediate the transport of tetracycline
    Babu, E
    Takeda, M
    Narikawa, S
    Kobayashi, Y
    Yamamoto, T
    Cha, SH
    Sekine, T
    Sakthisekaran, D
    Endou, H
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (01) : 69 - 76
  • [4] Role of human organic anion transporter 4 in the transport of ochratoxin A
    Babu, E
    Takeda, M
    Narikawa, S
    Kobayashi, Y
    Enomoto, A
    Tojo, A
    Cha, SH
    Sekine, T
    Sakthisekaran, D
    Endou, H
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1590 (1-3): : 64 - 75
  • [5] Genes and proteins involved in mesenchymal to epithelial transition
    Barasch, J
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (03) : 429 - 436
  • [6] BARNETT HL, 1949, PEDIATRICS, V3, P418
  • [7] Regulation of renal tubular secretion of organic compounds
    Berkhin, EB
    Humphreys, MH
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (01) : 17 - 30
  • [8] Inferring functional constraints and divergence in protein families using 3D mapping of phylogenetic information
    Blouin, C
    Boucher, Y
    Roger, AJ
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (02) : 790 - 797
  • [9] A novel putative transporter maps to the osteosclerosis (oc) mutation and is not expressed in the oc mutant mouse
    Brady, KP
    Dushkin, H
    Förnzler, D
    Koike, T
    Magner, F
    Her, H
    Gullans, S
    Segre, GV
    Green, RM
    Beier, DR
    [J]. GENOMICS, 1999, 56 (03) : 254 - 261
  • [10] Endocrine regulation of rat organic anion transporters
    Buist, SCN
    Cherrington, NJ
    Klaassen, CD
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 559 - 564
12345678910